Choroidal Blood Flow in Acute and Chronic Central Serous Chorioretinopathy
Recruiting
Observational Study
Central Serous Chorioretinopathy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 70
- Sex
- Any
- Study type
- Observational
- Participants needed
- 50 (estimated)
- Sponsor
- Helse Stavanger HF · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Patients with central serous chorioretinopathy (CSC) will be monitored with laser speckle flow graphy (LSFG), swept source optical coherence tomography (SS-OCT) and SS-OCT angiography (SS-OCTA). The aim is to unveil the flow and pulse wave characteristics of the choroidal circulation in acute CSC and chronic CSC.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:-
* Able to sign informed consent
* Possible to obtain fundus imaging
* Acute CSC ˂4 months of duration in one eye, defined as:
1. Subfoveal presence of SRF on OCT
2. Present attack is 1st -3rd attack of CSC
b) Patient history and examination consistent with acute CSC c) …
Contacts